Information about Lelima Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0691.649.590

VAT liability
Yes
Established
01-03-2018
Last balance sheet year
2025
Company size
Micro 0 FTE
Principal activity
Business and other management consultancy activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Lelima Pharma

2025 2024 2023 2022
Profit/Loss € 45,404 0 % € 45,392 3 % € 44,006 10 % € 39,978
Equity € 193,380 31 % € 147,976 44 % € 102,584 122 % € 46,178
Gross margin € 58,622 -8 % € 63,405 -1 % € 64,050 22 % € 52,704

Publications from Lelima Pharma

Date Publication
28-12-2022 Articles of Association (Translation, Coordination, Other Modifications, …) (FR)
30-11-2020 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations, Appointments (FR)
05-03-2018 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Lelima Pharma?
The VAT number of Lelima Pharma is BE 0691.649.590.
Wat is the PEPPOL ID of Lelima Pharma?
The PEPPOL ID of Lelima Pharma is 0208:0691649590. Log in or start a free trial to see the full overview.
When was Lelima Pharma founded?
Lelima Pharma was founded on 01-03-2018.
What is the address of Lelima Pharma?
The current registered office of Lelima Pharma is located at Rue Croix Thomas 6, 1341 Ottignies-Louvain-la-Neuve.
When was the last time Lelima Pharma filed their annual financial statements?
The most recent financial statements of Lelima Pharma were filed on 01-10-2025.
How many employees does Lelima Pharma have?
There are currently no employees working at Lelima Pharma or no workforce information is available.
What is the annual turnover of Lelima Pharma?
At the time of its most recent financial statements, Lelima Pharma did not publish any turnover figures. Lelima Pharma reported a gross margin of €58,622.19.

Sources